Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -5,905.91 | -17.45 |
PEG Ratio (TTM) | 103.38 | -5.51 |
P/S Ratio (TTM) | N/A | 34.30 |
P/B Ratio (TTM) | 3.48 | 5.71 |
P/FCF Ratio (TTM) | -190.56 | -146.76 |
Price to 5YR AVG Earnings Ratio | N/A | -34.28 |
Price to 5YR AVG FCF Ratio | N/A | -1.10 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.05% | 286.84% |
ROE (TTM) | -0.06% | -4,204.52% |
Net Profit Margin (TTM) | N/A | -1,029.21% |
ROIC 5YR AVG | N/A | -16.30% |
Growth (5%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 3.14% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -2.14% | N/A | N/A |
Cash Flow | -315.49% | N/A | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.01 | 4.92 |
Quick Ratio (TTM) | 0.01 | 4.90 |
D/E Ratio (TTM) | N/A | 1.27 |
Interest Coverage (TTM) | -2.17 | -11.13 |
Piotroski F-Score | 2 | 3 |
Altman Z-Score | 13.19 | 20.87 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 621.43% |